Perez-Lloret S et al: Adverse drug reactions to dopamine agonists: A comparative study in the French Pharmacovigilance Database. Mov Disord 2010;25:1876.
Sadeghi R, Ondo WG: Pharmacological management of essential tremor. Drugs 2010;70:2215.
Schapira AH et al: Assessment of safety and efficacy of safinamide as a levodopa adjunct in patients with Parkinson disease and motor fluctuations: A randomized clinical trial. JAMA Neurol 2017;74:216.
Schilsky ML: Wilson disease: Current status and the future. Biochimie 2009;91:1278.
Scott LJ: Gabapentin enacarbil: In patients with restless legs syndrome. CNS Drugs 2012;26:1073.
Seeberger LC, Hauser RA: Levodopa/carbidopa/entacapone in Parkinson’s disease. Expert Rev Neurother 2009;9:929.
Servello D et al: Deep brain stimulation in 18 patients with severe Gilles de la Tourette syndrome refractory to treatment: The surgery and stimulation. J Neurol Neurosurg Psychiatry 2008;79:136.
Simpson DM et al: Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 2016;86:1818.
Singer HS: Treatment of tics and Tourette syndrome. Curr Treat Options Neurol 2010;12:539.
Stocchi F et al: Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: The STRIDE-PD study. Ann Neurol 2010;68:18.
Tamara P et al: Tourette syndrome and other tic disorders of childhood. Handb Clin Neurol 2013;112:853.
Taylor RM et al: Triethylene tetramine dihydrochloride (trientine) in children with Wilson disease: Experience at King’s College Hospital and review of the literature. Eur J Pediatr 2009;168:1061.
Thomas R, Cavanna AE: The pharmacology of Tourette syndrome. J Neural Transm 2013;120:689.
Trenkwalder C, Paulus W: Restless legs syndrome: Pathophysiology, clinical presentation and management. Nat Rev Neurol 2010;6:337.
Van Holst RJ et al: Brain imaging studies in pathological gambling. Curr Psychiatry Rep 2010;12:418.
Videnovic A: Treatment of Huntington disease. Curr Treat Options Neurol 2013;15:424.
Vijayakumar D, Jankovic J: Drug-induced dyskinesias (2 parts). Drugs 2016;76:759 and 779.
Voon V et al: Impulse control disorders in Parkinson’s disease: A multicenter case-control study. Ann Neurol 2011;69:986.
Weaver FM et al: Randomized trial of deep brain stimulation for Parkinson disease: Thirty-six-month outcomes. Neurology 2012;79:55.
Wiggelinkhuizen M et al: Systematic review: Clinical efficacy of chelator agents and zinc in the initial treatment of Wilson disease. Aliment Pharmacol Ther 2009;29:947.